Adaptive drug escape of EML4-ALK lung cancer against targeted ALK inhibitor involving TGFβ2-mitochondrial priming

被引：0
|
作者：
Yin, Lihong [1 ]
Zhang, Wei [1 ]
Shi, Ivy [1 ]
Feng, Yan [1 ]
Bagai, Rakesh [1 ]
Lindner, Daniel [1 ]
Ma, Patrick C. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3718
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3718
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
  • [2] EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
    Choi, Young Lim
    Soda, Manabu
    Yamashita, Yoshihiro
    Ueno, Toshihide
    Takashima, Junpei
    Nakajima, Takahiro
    Yatabe, Yasushi
    Takeuchi, Kengo
    Hamada, Toru
    Haruta, Hidenori
    Ishikawa, Yuichi
    Kimura, Hideki
    Mitsudomi, Tetsuya
    Tanio, Yoshiro
    Mano, Hiroyuki
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1734 - 1739
  • [3] Epithelial-to-mesenchymal transition as an independent mechanism of ALK inhibitor resistance in EML4-ALK lung cancer
    Fukuda, Koji
    Takeuchi, Shinji
    Katayama, Ryohei
    Nanjo, Shigeki
    Tanimoto, Azusa
    Suzuki, Takeshi
    Takeuchi, Kengo
    Nishio, Makoto
    Yano, Seiji
    CANCER SCIENCE, 2018, 109 : 228 - 228
  • [4] Targeted therapies directed against EML4-ALK translocations and BRAF mutations in patients with lung cancer
    Johnson, B.
    EJC SUPPLEMENTS, 2009, 7 (04): : 4 - 4
  • [5] EML4-ALK AND OTHER FUSION KINASES IN LUNG CANCER
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S438
  • [6] EML4-ALK Translocation in Lung Cancer: An Institutional Clinical Experience
    Bertino, E. M.
    Zhao, W.
    Villalona-Calero, M.
    Otterson, G. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S532 - S532
  • [7] EML4-ALK fusion lung cancer:: A rare acquired event
    Perner, Sven
    Wagner, Patrick L.
    Demichelis, Francesca
    Mehra, Rohit
    LaFargue, Chris J.
    Moss, Benjamin J.
    Arbogast, Stefanie
    Soltermann, Alex
    Weder, Walter
    Giordano, Thomas J.
    Beer, David G.
    Rickman, David S.
    Chinnaiyan, Arul M.
    Moch, Holger
    Rubin, Mark A.
    NEOPLASIA, 2008, 10 (03): : 298 - 302
  • [8] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [9] PARACRINE RECEPTOR LIGANDS ACTIVATE BYPASS TRACTS AND CAUSE ALK INHIBITOR RESISTANCE IN EML4-ALK LUNG CANCER CELLS
    Yamada, Tadaaki
    Takeuchi, Shinji
    Nakade, Junya
    Nakagawa, Takayuki
    Nanjo, Shigeki
    Ebi, Hiromichi
    Nakamura, Takahiro
    Matsumoto, Kunio
    Soda, Manabu
    Mano, Hiroyuki
    Yano, Seiji
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S455 - S455
  • [10] Two novel EML4-ALK fusion variants involving EML4 exon 17 identified in lung cancer
    Li, Hai-Rong
    Sanders, Heather R.
    Sferruzza, Anthony D.
    Novic, Connie
    Meloni-Ehrig, Aurelia M.
    Albitar, Maher
    CANCER RESEARCH, 2010, 70
12345